Migraine and serotonin: mechanisms and treatments
Jacquy, J.
Journal de Pharmacie de Belgique 51(1): 43-46
1996
ISSN/ISBN: 0047-2166 PMID: 8882447 Document Number: 466683
Document emailed within 1 workday
Related Documents
Goadsby, P.J.; Hargreaves, R.J. 2000: Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan Neurology 55(9 Suppl 2): S8-S14Shimizu, T.; Suzuki, N. 2008: Recent topics on migraine: issues of the current treatments and new drugs for the treatment of migraine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 131(3): 210-214
Regli, F.; Nater, B.; Dworak, N. 1995: Stabilization treatments of migraine Praxis 84(38): 1032-1035
Kollin, E. 1971: Experience with a new serotonin antagonist in the prevention of migraine Orvosi Hetilap 112(35): 2090 Passim
Lance, J.W.; Anthony, M. 1970: A comparative trial of serotonin antagonists in the management of migraine Proceedings of the Australian Association of Neurologists 7: 31-35
Izzati-zade, K.F.; Chetvertnykh, V.A.; Shutov, A.A. 2011: The morphometric analysis of serotonin granules of platelets in migraine Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(10 Part 1): 58-61
D'Attoma, G.; Marconi, G.; Nacci, M.G. 1986: Desynchronization of serotonin, hemodynamic equilibrium and the recurrence of migraine crises Minerva Medica 77(30-31): 1445-1447
Fanchamps, A. 1982: The evolution of thinking about the role and site of action of serotonin in migraine Advances in Neurology 33: 31-33
Morotti, M.; Remorgida, V.; Buccelli, E.; Venturini, P.L.; Ferrero, S. 2012: Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura Journal of Comparative Effectiveness Research 1(4): 347-357
De Montigny, C. 1984: Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin Journal of Pharmacology and Experimental Therapeutics 228(1): 230-234
Blier, P.; de Montigny, C.; Chaput, Y. 1990: A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence Journal of Clinical Psychiatry 51 Suppl: 14-20; Discussion 21
Crown, W.H. 2000: Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression Acta Psychiatrica Scandinavica. Supplementum 403: 62-66
Akagawa, Y.; Masuda, Y.; Maruyama, A.; Shimizu, T.; Hishikawa, Y. 1999: Effects of repeated selective serotonin reuptake inhibitor paroxetine treatments on mouse forced swimming Methods and Findings in Experimental and Clinical Pharmacology 21(9): 599-601
Manivet, P.; Soliman, H.R.; Callebert, J.; Laplanche, J.L.; Launay, J.M. 2000: Biochemical mechanisms in the physiopathology of migraine Pathologie-Biologie 48(7): 630-641
Sulman, F.G.; Pfeifer, Y.; Superstine, E. 1981: Preventive treatment of serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94). A double-blind study Arzneimittel-Forschung 31(1): 109-112
Ghouzi, J. 2000: Recurrence: mechanisms and treatments L' Orthodontie Francaise 71(1): 61-67
Moskowitz, M.A.; Macfarlane, R. 1993: Neurovascular and molecular mechanisms in migraine headaches Cerebrovascular and Brain Metabolism Reviews 5(3): 159-177
Hansen, J.M.øl.; Ashina, M. 2016: Basic mechanisms of migraine and new methods of treatment Ugeskrift for Laeger 178(51)
Dugovic, C. 2001: Role of serotonin in sleep mechanisms Revue Neurologique (Paris) 157(11 Part 2): S16-S19
Kovaleva, I.I.; Lebedeva, A.V.; Shomakhova, M.M.; Magomedov, R.A. 2011: Migraine and epilepsy: clinical features and common pathogenetic mechanisms Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(10 Part 2): 59-62